Deslee G, Fabry-Vendrand C, Poccardi N, Thabut G, Eteve PitsaerC, CoriatA, Renaudat C, Maguire A, Pinto T. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France. BMJ Open Resp Res 2023;10:e001585. doi:10.1136/bmjresp-2022-00158​

Maguire A, Puelles J, Raboisson P et al. Early-stage Mycosis Fungoides: Epidemiology and Prognosis. Acta Dermato-Venereologica 2019 https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3367

Collings SL, Lefèvre C, Johnson ME, Evans D, Hack G, Stynes G, Maguire A. Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany. PLoS One. 2017 Oct 10;12(10)

Maguire A, Johnson ME, Denning DW, Ferreira GLC, Cassidy A. Identifying rare diseases using electronic medical records: the example of allergic bronchopulmonary aspergillosis. Pharmacoepidemiol Drug Saf. 2017 Mar 3

Lamy FX, Saragoussi D, Johnson ME, Guiraud-Diawara A, Jørgensen KT, Loze JY, Maguire A. The use of adjunctive antipsychotics to treat depression in UK primary care. Curr Med Res Opin. 2017 May;33(5):891-898

Gordon JP, McEwan PC, Maguire A, Sugrue DM, Puelles J. Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn's disease: a systematic review and clinician surveys. Eur J Gastroenterol Hepatol. 2015 Jul;27(7):804-12

Maguire A, Mitchell B, Cid-Ruzafa J. Antihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort study. BMC Endocrine Disorders 2014, 14:73

Khalid JM, Fox KM, Globe G, Maguire A, Chau D. Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England. Journal of Dermatological Treatment. 2014 Feb;25(1):67-72

Blak, B, Wilson K, Metcalfe M, Maguire A, Hards M. Evaluation of varenicline as an aid to smoking cessation in UK general practice –  a THIN database study. Current Medical Research & Opinion, 2010; 26(4): 861-70

Maguire A, Blak B, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiology and Drug Safety 2009; 18: 76–83

Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Pharmacoepidemiol & Drug Safety 2007; 16(4): 366-376

Varas-Lorenzo C, Garcia-Rodriguez LA, Maguire A, Gonzalez-Perez A. Non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. Circulation. 2004;109:3000-3006

Maguire A, Porta M, Sanz-Anquela JM, Ruano I, Malats N, Piñol JL. Sex as a prognostic factor in gastric cancer. Eur J Cancer 1996;32A:1303-9

Kalache A, Maguire A, Thompson S. Age at Last Full Term Pregnancy and Breast Cancer Risk. The Lancet 1993;341:32-35